• Ministry Releases Patient and Pharmacist Materials for OHIP+
• Statement from the Chief Public Health Officer of Canada, Dr. Theresa Tam, on the current measles outbreak and vaccine hesitancy
• Announcement from Indigenous Services Canada: Non-Insured Health Benefits (NIHB) Program - Coverage of Inhalers for the Treatment of Chronic Obstructive Pulmonary Disease (COPD)
• Interim Report on Pharmacare Released
• OPA Queen's Park Day - March 7, 2019
• CPhA Launches Women in Pharmacy Leadership Initiative

• Paid Consultations: Opportunities and Timesavers
• FAQs and a New Drug Update on Contraception and Abortion Care
• Identifying Drug Interactions

• Countdown to OPA Awards!
• Ask the Customer Experience and Administration Team
• Next OPA Webinar Wednesday Night

• Are You Prepared for a Critical Illness?
• It's Movie Ticket Time with COSECO!

• DDD Notice No. 19044 posted March 06, 2019 Prescription Forgery Alert
• DDD Notice No. 19045 posted March 06, 2019 Prescription Forgery Alert

• Recall - Multiple Losartan-containing drugs - Information Update

• OPA Q&A on OHIP+ for Children and Youth
• New Horizons in Pharmacy - Register for OPA webinar
• OPA Queen's Park Day - March 7, 2019
• Call for Applications for Canadian Foundation for Pharmacy 2019 Innovation Fund
• Save the Date - Canadian Foundation for Pharmacy Innovation Showcase, Building Bridges for Better Care

• FREE Opioid Addictions and Substitution Therapy Webinars
• Third Party Audit: An Introduction
• Personal Branding for Pharmacy Professionals

• Countdown to OPA Awards!
• Pharmacist Awareness Month Kicks Off at U of T
• Ask the Practice Support Network

• Buying or selling a pharmacy? How does this affect your insurance?
• It's Movie Ticket Time with COSECO!

• DDD Notice No.19039 posted February 27, 2019 Amendment to Ontario Regulation 201/96 made under the Ontario Drug Benefit Act to make changes to Ontario Drug Benefit Program coverage for children and youth aged 24 years and under (OHIP+)
• DDD Notice No.19040 posted February 28, 2019 Notice from the Executive Officer
• DDD Notice No. 19041 posted March 04, 2019 Prescription Forgery Alert
• IMPORTANT: Drug Shortage Notification - DEMULEN 30

• Ministry of Health and Long-Term Care proposes "Ontario Health"
• New Horizons in Pharmacy - Register for OPA webinar
• Weekly webinars on OHIP+ program launch April 1, 2019

• FAQs and a New Drugs Update on Contraception and Abortion Care
• Rational Prescribing - Re-thinking Medications
• Delivering a Comprehensive Pharmacy-based Vaccines Program

• March is Pharmacist Awareness Month - look who's representing
• Ask the Customer Experience and Administration Team
• Insurance Highlight: Deadline to purchase an Extended Reporting Period on your expired PLI policy is approaching

• DDD Notice No. 19036 ODB Formulary – Edition No. 43, Summary of Changes – February 2019
• DDD Notice No. 19037 posted February 22, 2019 Prescription Forgery Alert
• DDD Notice No. 19038 posted February 22, 2019 Prescription Forgery Alert
• Drug Supply Health System Alert: Epipen Auto-Injectors

• U of T startup raises $3.25 million to eliminate prescription opioids after surgery
• The Future of the Profession - Pharmacy in the 21st Century
• New Horizons in Pharmacy - Register for OPA's free webinar

• Asthma Management: The Essentials
• Drugs in Chronic Kidney Disease
• Pharmacist Health Coaching – Cardiovascular Program Training Course

• Who best to nominate you for the OPA Patient Impact Award than your patients?
• Ask the Practice Support Network
• Insurance Highlight: Is your store's insurance enough protection for you?
• Learn about the Insurance Committee's work on your behalf to ensure you are supported

• Drug Shortage Health System Alert: Potassium Chloride

• DDD Notice No. 19035 posted February 19, 2019 HEALTH NETWORK SYSTEM (HNS) AND NARCOTICS MONITORING SYSTEM (NMS) OUTAGE NOTIFICATION TO ODP AGENCIES
• DDD Notice No. 19034 posted February 15, 2019 Prescription Forgery Alert
• DDD Notice No.19031 posted February 14, 2019 Prescription Forgery Alert
• DDD Notice No.19030 posted February 13, 2019 Prescription Forgery Alert
• DDD Notice No.19029 posted February 13, 2019 Prescription Forgery Alert
• DDD Notice No.19028 posted February 13, 2019 Prescription Forgery Alert

• Health Canada recommends that children and youth not use cough and cold products that contain opioids

• Health Canada updates to opioid prescriptions
• Evaluation of the fentanyl patch-for-patch program in Ontario
• Non-Insured Health Benefits (NIHB) Program Notice
• Notification from Pfizer: Supply Interruptions – ZINECARD, 250 mg

• CDE Exam Preparation Course March 2-3, 2019
• Identifying Drug Interactions
• Point of Care Screening Programs in Community Pharmacy

• New Horizons in Pharmacy - Webinars with OPA Leadership
• Ask the Customer Experience and Administration Team
• Insurance Highlight: Q&A on the OPA Secure Health Plan
• OPA Cup - Celebrate Pharmacist Awareness Month and support your team!
• ICYMI: Have you seen our insurance product videos?

• Health Canada updating safety review of breast implants

• ICYMI: OPA recommendations to OHIP+ consultation
• ICYMI: OPA news release supporting "Devlin" report on Improving Health Care and Ending Hallway Medicine
• Have you got what it takes? OPA is hiring a new CEO!
• Research position with Ontario Pharmacy Evidence Network (OPEN)

• CDE Exam Preparation Course March 2-3, 2019
• Third Party Audits: An Introduction
• Selling What You Can Do For Your Clients

• What our members are saying
• Ask the Practice Support Network
• Insurance Highlight: Have you protected what pays for your car, home, and everything else? Watch our video.

• DDD Notice No. 19024 posted February 4, 2019 Notice from the Executive Officer
• DDD Notice No. 19023 posted February 1, 2019 Prescription Forgery Alert
• DDD Notice No. 19022 posted January 31, 2019 Notice from the Executive Officer
• DDD Notice No. 19021 posted January 30, 2019 Prescription Forgery Alert

• Important deadline approaching for PLI insurance
• Bell Let's Talk Day resources and information for pharmacy
• Health Canada resources for managing opioids
• Pain competence assessment tool (PCAT) survey from the Musculoskeletal Program at Toronto Rehabilitation Institute (TRI)
• New tool for veterinary antimicrobial sales reporting

• FREE! New live opioid webinars - four sessions to choose from
• 2019 Board Certified Geriatric Pharmacist Exam Prep Course - online
• CV Health Coaching for Pharmacists – Cardiovascular Training

• Who best to nominate you for the OPA Patient Impact Award than your patients?
• Ask the Customer Experience and Administration Team
• Insurance Highlight: Why do I need disability insurance?
• Winter promotion - OPA members receive 20% off admission to Museum of Illusions
• Last week for eBulletin and eDIRC for those who have not renewed their membership or subscription

• DDD Notice No. 19020 posted January 28, 2019 Prescription Forgery Alert
• DDD Notice No. 19019 posted January 23, 2019 ODB FORMULARY – EDITION NO. 43, Summary of Changes – January 2019
• DDD Notice No. 19018 posted January 23, 2019 Prescription Forgery Alert

• Health Canada updates to opioid prescriptions
• Evaluation of the fentanyl patch-for-patch program in Ontario
• Non-Insured Health Benefits (NIHB) Program Notice
• Notification from Pfizer: Supply Interruptions – ZINECARD, 250 mg

• CDE Exam Preparation Course March 2-3, 2019
• Identifying Drug Interactions
• Point of Care Screening Programs in Community Pharmacy

• New Horizons in Pharmacy - Webinars with OPA Leadership
• Ask the Customer Experience and Administration Team
• Insurance Highlight: Q&A on the OPA Secure Health Plan
• OPA Cup - Celebrate Pharmacist Awareness Month and support your team!
• ICYMI: Have you seen our insurance product videos?

• Health Canada updating safety review of breast implants